Peripheral Serotonin: a New Player in Systemic Energy Homeostasis

다국어 초록 (Multilingual Abstract)

Whole body energy balance is achieved through the coordinated regulation of energy intake and energy expenditure in various tissues including liver, muscle and adipose tissues. A positive energy imbalance by excessive energy intake or insufficient energy expenditure results in obesity and related metabolic diseases. Although there have been many obesity treatment trials aimed at the reduction of energy intake, these strategies have achieved only limited success because of their associated adverse effects. An ancient neurotransmitter, serotonin is among those traditional pharmacological targets for anti-obesity treatment because it exhibits strong anorectic effect in the brain.
However, recent studies suggest the new functions of peripheral serotonin in energy homeostasis ranging from the endocrine regulation by gut-derived serotonin to the autocrine/ paracrine regulation by adipocyte-derived serotonin.
Here, we discuss the role of serotonin in the regulation of energy homeostasis and introduce peripheral serotonin as a possible target for anti-obesity treatment.

참고문헌 (Reference)

1 Keszthelyi, D., "Understanding the role of tryptophan and serotonin metabolism in gastrointestinal function" 21 : 1239-1249, 2009

2 Zhang, X., "Tryptophan hydroxylase-2 controls brain serotonin synthesis" 305 : 217-, 2004

3 Gershon, M. D., "The serotonin signaling system : from basic understanding to drug development for functional GI disorders" 132 : 397-414, 2007

4 Young, S. N., "The role of serotonin in human mood and social interaction : Insight from altered tryptophan levels" 71 : 857-865, 2002

5 Brand, T., "The measurement of plateletpoor plasma serotonin : a systematic review of prior reports and recommendations for improved analysis" 57 : 1376-1386, 2011

6 Merens, W., "The effects of serotonin manipulations on emotional information processing and mood" 103 : 43-62, 2007

7 Colman, E., "The FDA's assessment of two drugs for chronic weight management" 367 : 1577-1579, 2012

8 Halford, J. C. G., "The 5-HT1B receptor agonist CP-94, 253 reduces food intake and preserves the behavioural satiety sequence" 60 : 933-939, 1996

9 Murphy, D. L., "Targeting the murine serotonin transporter : insights into human neurobiology" 9 : 85-96, 2008

10 Heal, D. J., "Sibutramine : a novel anti-obesity drug. A review of the pharmacological evidence to differentiate it from d-amphetamine and d-fenfluramine" 22 (22): 18-28, 1998

11 Kim, H., "Serotonin regulates pancreatic beta cell mass during pregnancy" 16 : 804-808, 2010

12 Matsuda, M., "Serotonin regulates mammary gland development via an autocrine-paracrine loop" 6 : 193-203, 2004

13 Ohara-Imaizumi, M., "Serotonin regulates glucose-stimulated insulin secretion from pancreatic β cells during pregnancy" 110 : 19420-19425, 2013

14 Haub, S., "Serotonin receptor type 3 antagonists improve obesity-associated fatty liver disease in mice" 339 : 790-798, 2011

15 Monti, J. M., "Serotonin control of sleep-wake behavior" 15 : 269-281, 2011

16 Lam, D. D., "Serotonin and energy balance : molecular mechanisms and implications for type 2 diabetes" 9 : 1-24, 2007

17 Lam, D. D., "Serotonin 5-HT2C receptor agonist rromotes hypophagia via downstream activation of melanocortin 4 receptors" 149 : 1323-1328, 2008

18 Zhou, L., "Serotonin 2C receptor agonists improve type 2 diabetes via melanocortin-4 receptor signaling pathways" 6 : 398-405, 2007

19 Oh, C. M., "Regulation of systemic energy homeostasis by serotonin in adipose tissues" 6 : 6794-, 2015

20 Kinoshita, M., "Regulation of adipocyte differentiation by activation of serotonin(5-HT)receptors 5-HT2AR and 5-HT2CR and involvement of microRNA-448-mediated repression of KLF5" 24 : 1978-1987, 2010

21 Vickers, S. P., "Reduced satiating effect of d-fenfluramine in serotonin 5-HT2C receptor mutant mice" 143 : 309-314, 1999

22 Collins, S., "Positive and negative control of Ucp1 gene transcription and the role of [beta]-adrenergic signaling networks" 34 : 28-33, 2010

23 Moore, M. C., "Portal infusion of a selective serotonin reuptake inhibitor enhances hepatic glucose disposal in conscious dogs" 287 : 1057-1063, 2004

24 Lesurtel, M., "Platelet-derived serotonin mediates liver regeneration" 312 : 104-107, 2006

25 Watanabe, H., "Peripheral serotonin enhances lipid metabolism by accelerating bile acid turnover" 151 : 4776-4786, 2010

26 Gres, S., "Oxidation of high doses of serotonin favors lipid accumulation in mouse and human fat cells" 57 : 1089-1099, 2013

27 Sohn, J. W., "Neuronal circuits that regulate feeding behavior and metabolism" 36 : 504-512, 2013

28 Hannon, J., "Molecular biology of 5-HT receptors" 195 : 198-213, 2008

29 Kim, H. J., "Metabolomic analysis of livers and serum from high-fat diet induced obese mice" 10 : 722-731, 2011

30 Bouwknecht, J. A., "Male and female 5-HT(1B)receptor knockout mice have higher body weights than wildtypes" 74 : 507-516, 2001

31 Yadav, V. K., "Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum" 135 : 825-837, 2008

32 Martin, C. K., "Lorcaserin, a 5-HT(2C)receptor agonist, reduces body weight by decreasing energy intake without influencing energy expenditure" 96 : 837-845, 2010

33 Gershon, M. D., "Location of sites of 5-hydroxytryptamine storage and metabolism by radioautography" 186 : 477-492, 1966

34 Wade, P. R., "Localization and function of a 5-HT transporter in crypt epithelia of the gastrointestinal tract" 16 : 2352-2364, 1996

35 Nonogaki, K., "Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene" 4 : 1152-1156, 1998

36 Le Feuvre, R. A., "Involvement of corticotrophin releasing factor(CRF)in the thermogenic and anorexic actions of serotonin(5-HT)and related compounds" 555 : 245-250, 1991

37 Crane, J. D., "Inhibiting peripheral serotonin synthesis reduces obesity and metabolic dysfunction by promoting brown adipose tissue thermogenesis" 21 : 166-172, 2015

38 Gutknecht, L., "Impacts of brain serotonin deficiency following Tph2inactivation on development and raphe neuron serotonergic specification" 7 : 43157-, 2012

39 Breisch, S. T., "Hyperphagia and obesity following serotonin depletion by intraventricular pchlorophenylalanine" 192 : 382-385, 1976

40 Sumara, G., "Gut-derived serotonin is a multifunctional determinant to fasting adaptation" 16 : 588-600, 2012

41 Alenina, N., "Growth retardation and altered autonomic control in mice lacking brain serotonin" 106 : 10332-10337, 2009

42 Savelieva, K. V., "Genetic disruption of both tryptophan hydroxylase genes dramatically reduces serotonin and affects behavior in models sensitive to antidepressants" 3 : 3301-, 2008

43 Kim, K., "Functional role of serotonin in insulin secretion in a diet-induced insulin-resistant state" 156 : 444-452, 2015

44 Heisler, L. K., "Fluoxetine decreases fat and protein intakes but not carbohydrate intake in male rats" 58 : 767-773, 1997

45 Kennett, G. A., "Evidence that hypophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptors" 96 : 93-100, 1988

46 Feldman, J. M., "Effect of the monoamine oxidase inhibitors clorgyline and pargyline on the hyperphagia of obese mice" 29 : 147-158, 1988

47 Sakaguchi, T., "Effect of norepinephrine, serotonin and tryptophan on the firing rate of sympathetic nerves" 492 : 271-280, 1989

48 Arase, K., "Effect of fenfluramine on sympathetic firing rate" 29 : 675-680, 1988

49 Rothwell, N. J., "Effect of diet and fenfluramine on thermogenesis in the rat : possible involvement of serotonergic mechanisms" 11 : 319-324, 1987

50 Tecott, L. H., "Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors" 374 : 542-546, 1995

51 Lam, D. D., "Brain serotonin system in the coordination of food intake and body weight" 97 : 84-91, 2010

52 Serretti, A., "Antidepressants and body weight : a comprehensive review and meta-analysis" 71 : 1259-1272, 2010

53 Heisler, L. K., "Activation of central melanocortin pathways by fenfluramine" 297 : 609-611, 2002

54 Walther, D. J., "A unique central tryptophan hydroxylase isoform" 66 : 1673-1680, 2003

55 Yamakawa, J., "A novel serotonin blocker, sarpogrelate, increases circulating adiponectin levels in diabetic patients with arteriosclerosis obliterans" 26 : 2477-2478, 2003

56 Bertrand, R. L., "A Western diet increases serotonin availability in rat small intestine" 152 : 36-47, 2011

57 Uchida-Kitajima, S., "5-Hydroxytryptamine 2A receptor signaling cascade modulates adiponectin and plasminogen activator inhibitor 1 expression in adipose tissue" 582 : 3037-3044, 2008

58 Nomura, S., "5-HT2A receptor antagonist increases circulating adiponectin in patients with type 2 diabetes" 16 : 423-428, 2005